MarketWatchCenter·
Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals
Novo Nordisk stock tumbled on Monday as the weight-loss drug manufacturer failed to excite investors hoping for a turnaround.
Read at MarketWatch →
Markets · 1 sources covering this
Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals
Novo Nordisk stock tumbled on Monday as the weight-loss drug manufacturer failed to excite investors hoping for a turnaround.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/d0e48921473614b4b88b630e9d14faaf5dc0533a" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Novo Nordisk stock tumbles as Ozempic maker sets out 2030 goals"></iframe>
